These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 4404070)
21. Kinetic parameters of a new narcotic agonist, azidomorphine. Knoll J; Fürst S; Vizi ES Pharmacology; 1973; 10(6):354-62. PubMed ID: 4784366 [No Abstract] [Full Text] [Related]
22. Responses of isolated dog small intestine to analgesic agents. Burks TF; Long JP J Pharmacol Exp Ther; 1967 Nov; 158(2):264-71. PubMed ID: 6065149 [No Abstract] [Full Text] [Related]
23. Studies on the receptors involved in the action of the various agents in the phenylbenzoquinone analgesic assay in mice. Smits SE; Takemori AE Br J Pharmacol; 1970 Jul; 39(3):639-46. PubMed ID: 5472209 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological properties related to the mechanism of action of potent analgesic drugs. Winter CA Pure Appl Chem; 1969; 19(1):77-88. PubMed ID: 4391527 [No Abstract] [Full Text] [Related]
25. SOME NARCOTIC ANTAGONISTS IN THE BENZOMORPHAN SERIES. HARRIS LS; PIERSON AK J Pharmacol Exp Ther; 1964 Feb; 143():141-8. PubMed ID: 14163985 [No Abstract] [Full Text] [Related]
26. Central neurohumoral systems involved with narcotic agonists and antagonists. Harris LS Fed Proc; 1970; 29(1):28-31. PubMed ID: 4391649 [No Abstract] [Full Text] [Related]
27. Potent long-acting antagonists of the 9,9-dialkylbenzomorphan series. Janssen PA Adv Biochem Psychopharmacol; 1973; 8(0):109-11. PubMed ID: 4795015 [No Abstract] [Full Text] [Related]
28. Antagonism of the behavioral effects of morphine and methadone by narcotic antagonists in the pigeon. McMillan DE; Wolf PS; Carchman RA J Pharmacol Exp Ther; 1970 Nov; 175(2):443-58. PubMed ID: 5481709 [No Abstract] [Full Text] [Related]
29. Assaying narcotic-antagonist drugs for analgesic activity in rhesus monkeys. Malis JL; Gluckman MI Adv Biochem Psychopharmacol; 1973; 8(0):225-33. PubMed ID: 4211815 [No Abstract] [Full Text] [Related]
30. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys. Cowan A Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992 [No Abstract] [Full Text] [Related]
31. Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. Lorenzetti OJ; Sancilio LF Arch Int Pharmacodyn Ther; 1970 Feb; 183(2):391-402. PubMed ID: 5466233 [No Abstract] [Full Text] [Related]
34. The effects of narcotic analgesics and narcotic antagonists on ganglionic transmission in the rat. Forbes JE; Dewey WL Life Sci; 1976 Aug; 19(3):401-7. PubMed ID: 183075 [No Abstract] [Full Text] [Related]
35. The pharmacology of (minus)-3-hydroxy-N-cyclopropylmethylmorphinan (cyclorphan). Harris LS; Pierson AK; Dembinski JR; Dewey WL Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):112-26. PubMed ID: 4382141 [No Abstract] [Full Text] [Related]
36. Elaboration of a bradykinin-like substance in dog's canine pulp during electrical stimulation and its inhibition by narcotic and nonnarcotic analgesics. Inoki R; Toyoda T; Yamamoto I Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(4):387-98. PubMed ID: 4273714 [No Abstract] [Full Text] [Related]